Skip to main content
NVDA+0.06%AAPL-0.17%GOOGL+0.97%MSFT-0.03%AMZN+0.02%TSM-1.02%SPCX+1.25%META-0.15%AVGO+0.39%TSLA+0.04%SKHY-0.86%MU+0.02%BRK-B+0.86%LLY+0.83%AMD-2.03%JPM+0.47%WMT+0.71%V+2.76%XOM+0.26%ASMLa-0.07%JNJ+1.93%INTC-2.22%MA+2.50%0700.HK-0.16%ABBV+1.49%CSCO+3.05%1398.HK-0.70%CVX+0.20%COST-0.11%ORCL+4.30%AP2d-0.05%AMAT-0.50%LRCX-0.55%DELL+2.04%BAC+1.32%KO+0.32%CAT+0.54%PG+0.42%UNH+2.25%3988.HK-0.94%1816.HK+0.45%0005.HK-0.03%GE+0.84%HSBA.L0.00%PM+0.34%0857.HK+0.20%0939.HK-0.51%MS+1.38%NFLX-1.77%1288.HK-0.81%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURSEK0.00%CADJPY0.00%GBPNZD0.00%CADCHF0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%USDZAR0.00%USDHKD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.18%ETHUSD+15.73%USDTUSD+0.01%XRPUSD+7.53%SOLUSD+8.55%TRXUSDT-0.18%ZECUSDT+1.98%DOGEUSD+9.80%XMRUSDT+1.56%LINKUSD+11.71%XLMUSD+1.12%BCHUSDT+0.77%LTCUSD+5.41%UNIUSD+1.60%SUIUSD+3.10%HBARUSDT+0.14%TONUSD+17.89%TAOUSDT+2.48%AAVEUSD+3.93%DOTUSDT+1.11%ICPUSDT+2.53%ONDOUSDT+3.16%WLDUSDT+14.95%JUPUSDT-0.63%ARBUSDT+0.73%ATOMUSDT-6.30%STXUSDT-0.79%INJUSDT+1.36%FETUSDT+3.81%PYTHUSDT-1.75%SEIUSDT+1.92%TIAUSDT+2.46%IMXUSDT-1.66%GRTUSDT-0.77%OPUSDT+3.88%IOTAUSDT+3.71%WIFUSDT+0.14%AXSUSDT+3.45%POLUSDT-0.42%FARTCOINUSDT+2.79%EOSUSDT+8.36%DYDXUSDT+0.43%GALAUSDT+2.70%ORDIUSDT+5.66%RONINUSDT+8.48%NOTUSDT+6.90%NVDA+0.06%AAPL-0.17%GOOGL+0.97%MSFT-0.03%AMZN+0.02%TSM-1.02%SPCX+1.25%META-0.15%AVGO+0.39%TSLA+0.04%SKHY-0.86%MU+0.02%BRK-B+0.86%LLY+0.83%AMD-2.03%JPM+0.47%WMT+0.71%V+2.76%XOM+0.26%ASMLa-0.07%JNJ+1.93%INTC-2.22%MA+2.50%0700.HK-0.16%ABBV+1.49%CSCO+3.05%1398.HK-0.70%CVX+0.20%COST-0.11%ORCL+4.30%AP2d-0.05%AMAT-0.50%LRCX-0.55%DELL+2.04%BAC+1.32%KO+0.32%CAT+0.54%PG+0.42%UNH+2.25%3988.HK-0.94%1816.HK+0.45%0005.HK-0.03%GE+0.84%HSBA.L0.00%PM+0.34%0857.HK+0.20%0939.HK-0.51%MS+1.38%NFLX-1.77%1288.HK-0.81%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURSEK0.00%CADJPY0.00%GBPNZD0.00%CADCHF0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%USDZAR0.00%USDHKD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.18%ETHUSD+15.73%USDTUSD+0.01%XRPUSD+7.53%SOLUSD+8.55%TRXUSDT-0.18%ZECUSDT+1.98%DOGEUSD+9.80%XMRUSDT+1.56%LINKUSD+11.71%XLMUSD+1.12%BCHUSDT+0.77%LTCUSD+5.41%UNIUSD+1.60%SUIUSD+3.10%HBARUSDT+0.14%TONUSD+17.89%TAOUSDT+2.48%AAVEUSD+3.93%DOTUSDT+1.11%ICPUSDT+2.53%ONDOUSDT+3.16%WLDUSDT+14.95%JUPUSDT-0.63%ARBUSDT+0.73%ATOMUSDT-6.30%STXUSDT-0.79%INJUSDT+1.36%FETUSDT+3.81%PYTHUSDT-1.75%SEIUSDT+1.92%TIAUSDT+2.46%IMXUSDT-1.66%GRTUSDT-0.77%OPUSDT+3.88%IOTAUSDT+3.71%WIFUSDT+0.14%AXSUSDT+3.45%POLUSDT-0.42%FARTCOINUSDT+2.79%EOSUSDT+8.36%DYDXUSDT+0.43%GALAUSDT+2.70%ORDIUSDT+5.66%RONINUSDT+8.48%NOTUSDT+6.90%
OM

Omnicell, Inc. (OMCL)

NASDAQ • Healthcare

$35.82
+$0.99 (+2.8%)
Market closed

Last close at October 9, 2026 at 20:00 UTC

Open$35.25
Day Range$35.17 - $36.05
Avg. Volume (3M)507.5K
Market Cap$1.6B
P/E Ratio42.1
52 Week Range
$29.06$55
Next EarningsIn 19 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$312.2M100%
Gross Profitminus cost of goods$152.9M49%
Operating Incomeminus R&D and overhead$32.4M10%
Net Incomeminus taxes and the rest$24.2M8%

In plain terms: out of every $100 in revenue, Omnicell, Inc. keeps $8 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.2B
Net Income (TTM)
$39M
EPS (TTM)
$0.85
ROA (TTM)
1.96%
Current Ratio
1.64

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-14.9%Q1 2026$0.4
+66.7%Q2 2026$0.55
+101.1%Q3 2026$0.94
Next

Oct 29

in 19 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +101.1%

Omnicell beat expectations on earnings while revenue came in line in the second fiscal quarter of 2026, reported July 30, 2026, with adjusted EPS of $0.94 topping the $0.47 estimate (+101%) as revenue of $312.2 million landed in line with the $310.2 million consensus (+0.6%). Revenue rose 7.4% to about $312.2 million (up from roughly $290.6 million a year ago), led by Connected devices, software licenses, and other at around $149.2 million, up 7.7% year over year, while SaaS and Expert Services contributed roughly $68.6 million, up 7.8%; geographically, the United States remained the largest market at about $281.0 million, up 6.7%, with Rest of world at roughly $31.2 million, up 15.0%. Profitability ran at a gross margin of 49.0% and an operating margin of 10.4%, with gross profit of about $152.9 million and operating income of roughly $32.4 million, and net income increased 330.7% to about $24.3 million (up from roughly $5.6 million a year ago). The company generated operating cash flow of about $69.5 million and repurchased roughly $0.4 million of stock. Next-period consensus calls for EPS of $0.42 on revenue of $304.4 million.

Next report — what to expect

Omnicell, Inc. (OMCL) reports next on October 29, 2026. Wall Street is looking for EPS of $0.42 on revenue of $304.4 million. For trailing context, revenue grew +7.4% year over year last quarter. OMCL has beaten EPS in 7 of 8 most recent quarters, putting focus on any repeat vs consensus.

View full earnings history

About Omnicell, Inc.

Omnicell, Inc. (NASDAQ: OMCL) provides medication management technology and services for healthcare providers, combining automation, software, and pharmacy workflows across the medical information services area. The company generated $1.2 billion of revenue in FY2025 from hospital and health systems solutions, pharmacy platforms, and related support offerings.

Name
Omnicell, Inc.
CEO
Randall A. Lipps
Industry
Healthcare
Year Founded
1992
Employees
3,485

Today's Snapshot

AI-generated

OMCL closed 2.8% higher at 35.82, in line with a firmer sector. Shares changed hands at about two-thirds of its usual level. Omnicell forecast weak operating profit.

Trading Volume

Below 10d avg (493.9K)

303K

vs S&P 500 Today

Outperforming Market

+2.25%

Updated: October 9, 2026 at 20:31 UTC

Technical Indicators

4 Buy1 Neutral3 Sell
OMCL shows a mixed technical profile that supports a neutral stance: trend strength is muted with ADX under 20, while momentum indicators are conflicted—CCI and MACD lean positive but stochastic and Williams readings suggest short-term overbought conditions. Price sits above most short- and medium-term averages, yet longer-term 100- and 200-day moving averages remain higher, creating a split between near-term strength and longer-term resistance. Volume-based OBV is constructive and ATR indicates moderate volatility, with the pivot beneath the market. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$34.29 - $37.97
    Buy
  • RSI (14)60.17
    Neutral
  • Stochastic %K (14, 3, 3)82.37
    Sell
  • MACD Level (12, 26)0.14
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.